← Leaderboards
John A Olson
Washington University
$6,092,537
Attributed
$6,924,232
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,057,710 · 7
By mechanism
R01$5,145,716 · 3
U54$1,133,478 · 1
R38$846,106 · 1
K23$655,210 · 1
R21$277,200 · 1
Top collaborators
- James Koh5 shared
- Li Ding1 shared
- Ramaswamy Govindan1 shared
Most similar at Washington University
Same institution · by research overlap
- Ross Leigh Cagan$25,056,984
- Kelly R Monk$11,142,470
- Shadmehr Demehri$14,520,225
- Sarah D Ackerman$1,870,492
- Mitchell R D'rozario$80,832
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsOperative Surgical ProceduresFoundationsParathyroid AdenomaMetabolic DiseasesCellsParathyroid GlandHyperparathyroidismBiochemicalLaboratoriesMolecularBaseFeedbackNeoplasmsExcisionCohortIndexingHeterogeneityGlandLeadParathyroid NeoplasmsPathogenesisPostmenopauseTumor
Grant awards (21)
Washington University PDX Development and Trial Center$1,133,478
U54 · FY2025 · CA
StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training$423,053
R38 · FY2025 · CA · contact PI
StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training$423,053
R38 · FY2024 · CA · contact PI
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism$662,448
R01 · FY2023 · CA · contact PI
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism$551,631
R01 · FY2022 · CA · contact PI
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism$622,913
R01 · FY2021 · CA · contact PI
Mechanisms of activation, signaling and trafficking of adhesion GPCRs GPR64 and GPR56$310,103
R01 · FY2021 · GM · contact PI
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism$634,474
R01 · FY2020 · CA · contact PI
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism$700,756
R01 · FY2019 · CA · contact PI
Molecular Mechanisms of Altered Calcium Sensing in Human Parathyroid Disease$318,747
R01 · FY2014 · DK · contact PI
Molecular Mechanisms of Altered Calcium Sensing in Human Parathyroid Disease$307,591
R01 · FY2013 · DK · contact PI
Molecular Mechanisms of Altered Calcium Sensing in Human Parathyroid Disease$318,747
R01 · FY2012 · DK · contact PI
Molecular mechanisms of altered calcium sensing in human parathyroid disease$326,015
R01 · FY2011 · DK · contact PI
Molecular mechanisms of altered calcium sensing in human parathyroid disease$392,291
R01 · FY2010 · DK · contact PI
Developing Biomarker-Based Prognostics In Breast Cancer$131,042
K23 · FY2008 · CA · contact PI
Developing Biomarker-Based Prognostics In Breast Cancer$131,042
K23 · FY2007 · CA · contact PI
Developing Biomarker-Based Prognostics In Breast Cancer$131,042
K23 · FY2006 · CA · contact PI
Improving genomic prediction models in breast cancer$138,600
R21 · FY2005 · CA
Developing Biomarker-Based Prognostics In Breast Cancer$131,042
K23 · FY2005 · CA
Improving genomic prediction models in breast cancer$138,600
R21 · FY2004 · CA
Developing Biomarker-Based Prognostics In Breast Cancer$131,042
K23 · FY2004 · CA